Year |
Citation |
Score |
2014 |
Brailoiu GC, Deliu E, Marcu J, Hoffman NE, Console-Bram L, Zhao P, Madesh M, Abood ME, Brailoiu E. Differential activation of intracellular versus plasmalemmal CB2 cannabinoid receptors. Biochemistry. 53: 4990-9. PMID 25033246 DOI: 10.1021/Bi500632A |
0.601 |
|
2014 |
Shore DM, Baillie GL, Hurst DH, Navas F, Seltzman HH, Marcu JP, Abood ME, Ross RA, Reggio PH. Allosteric modulation of a cannabinoid G protein-coupled receptor: binding site elucidation and relationship to G protein signaling. The Journal of Biological Chemistry. 289: 5828-45. PMID 24366865 DOI: 10.1074/Jbc.M113.478495 |
0.594 |
|
2013 |
Marcu J, Shore DM, Kapur A, Trznadel M, Makriyannis A, Reggio PH, Abood ME. Novel insights into CB1 cannabinoid receptor signaling: a key interaction identified between the extracellular-3 loop and transmembrane helix 2. The Journal of Pharmacology and Experimental Therapeutics. 345: 189-97. PMID 23426954 DOI: 10.1124/Jpet.112.201046 |
0.566 |
|
2013 |
Marcu J, Console-Bram L, Abood ME. Current cannabinoid receptor nomenclature and pharmacological principles Endocannabinoid Regulation of Monoamines in Psychiatric and Neurological Disorders. 25-54. DOI: 10.1007/978-1-4614-7940-6_3 |
0.655 |
|
2012 |
Console-Bram L, Marcu J, Abood ME. Cannabinoid receptors: nomenclature and pharmacological principles. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 38: 4-15. PMID 22421596 DOI: 10.1016/J.Pnpbp.2012.02.009 |
0.635 |
|
2010 |
Marcu JP, Christian RT, Lau D, Zielinski AJ, Horowitz MP, Lee J, Pakdel A, Allison J, Limbad C, Moore DH, Yount GL, Desprez PY, McAllister SD. Cannabidiol enhances the inhibitory effects of delta9-tetrahydrocannabinol on human glioblastoma cell proliferation and survival. Molecular Cancer Therapeutics. 9: 180-9. PMID 20053780 DOI: 10.1158/1535-7163.MCT-09-0407 |
0.364 |
|
Show low-probability matches. |